Clinical Trials on Relapsed

Total 50408 results

Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Feasibility Study of Take-Home LAAM Medication - 3

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute on Drug Abuse (NIDA)

Completed

Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9

Opioid-Related Disorders

United States
University of Pennsylvania

Completed

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Opioid-Related Disorders

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Naltrexone-P1 A-Cocaine

Cocaine-related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 3 - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate-Day Buprenorphine Administration. Phase VIII - 9

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Tramadol as a Treatment for Opioid Addiction

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Alcohol Related Disorders

United States, Canada
US Department of Veterans Affairs

Completed

Effect Of Case Management Following Discharge From Methadone Treatment

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

Leveraging Regulatory Flexibility for Methadone Take-Home Dosing to Improve Retention in Treatment for Opioid Use Disorder

Problems Related to Social Environment

United States
Chestnut Health Systems

Recruiting

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR (PRE-FAIR)

Opioid-Related Disorders | Mental Health Impairment | Child Neglect | Stimulant-Related Disorder

United States
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
Washington University School of Medicine

Recruiting

Improving Health and Employment Outcomes Through Workplace Opioid Policies

Opioid-Related Disorders

United States
Biomedical Development Corporation
National Institute on Drug Abuse (NIDA); The University of Texas Health Science...

Active, not recruiting

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder (KIOS-I)

Opioid-Related Disorders

United States
Karlstad Central Hospital

Completed

Intrathecal Morphine for Robotic-assisted Laparoscopic Hysterectomy.

Opioid-Related Disorders

Sweden
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS)

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Maryland, Baltimore

Completed

Youth Opioid Recovery Support: Improving Care Systems (YORS)

Opioid-Related Disorders

United States
Duke University
Alkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources... and other collaborators

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings (DC)

Opioid-Related Disorders

United States
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Contingency Management Treatment for Crack Addiction - Study With Brazilian Population

Cocaine Related Disorders

Brazil
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); Office of Research on Women's Health...

Completed

The Effect of Yohimbine on Cocaine Cue Reactivity

Cocaine Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Activity Monitoring Assessment of Opiate Withdrawal - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center

Completed

Comparison of Buprenorphine and Methadone - 3

Opioid-Related Disorders

United States
University of California, Los Angeles

Completed

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Britannia Pharmaceuticals Ltd.

Completed

Lofexidine for Opiate Withdrawal - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Clinical Rescue Protocol - 2

Opioid-Related Disorders

United States
Boston Children's Hospital

Withdrawn

Computerized Alcohol Screening for Children and Adolescents (cASCA)

Alcohol Related Disorders

United States
University of Malaya
National Institute on Drug Abuse (NIDA); National Institute of Mental Health... and other collaborators

Terminated

Comparative Evaluation of PUSPENs and C&Cs (PSVCC)

Opioid-Related Disorders
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 2 - 2

Opioid-Related Disorders

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

Neurobiology of Opioid Dependence: 5 - 5

Opioid-Related Disorders

United States
University Hospital, Basel, Switzerland

Completed

Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial

Cocaine-related Disorders

Switzerland

Clinical Trials on Relapsed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations